News

Introns in DNA, Largely Ignored, May Be Parkinson Determinants

Researchers have identified distinct changes to introns — a historically understudied component of genes — associated with the presence and progression of Parkinson’s disease. Learning more about these changes and the signaling pathways they impact may help in identifying biomarkers and treatment targets for the neurodegenerative disease, the researchers…

Delirium Common But Often Not Noted on Medical Records

Although common, delirium often goes undocumented in the medical records of many Parkinson’s patients who experience the symptoms, results from a new study show, and those who have been diagnosed with delirium often lack instructions for future care. The study, “Documentation and Diagnosis of Delirium in Parkinson’s…

To Help Underserved Patients, APDA Offers 2 Key Resources in Chinese

The American Parkinson Disease Association (APDA)  is now offering two key resources in simplified Chinese — part of the nonprofit’s ongoing efforts to reach and support more Parkinson’s disease patients and caregivers, particularly in underrepresented communities. The newly transcreated free resources, written in Chinese characters, are the APDA’s…

New Method May Help Diagnose Parkinson’s Using a Blood Test

A novel method that involves looking for disease-associated alpha-synuclein inside of neuron-derived extracellular vesicles — packets of cellular cargo that are released by nerve cells in the brain, and can be isolated in a person’s blood — may help to diagnose and monitor the progression of Parkinson’s disease. A…

Poor Sleep Seems to Worsen Parkinson’s Symptoms

Poor quality of sleep is linked to worse motor and nonmotor symptoms in people with Parkinson’s disease, a study has found. Greater deviations from an estimated ideal bedtime, time in bed, and duration of sleep are linked to more severe symptoms, data show. “Sleep disorders have a significant effect…

Genetic Mutations May Affect Parkinson’s Progression

Certain genetic mutations may help determine the length of survival in Parkinson’s disease patients, according to findings by a team of researchers from four institutes in Paris. Patients with Parkinson’s who carried a mutation in either the LRRK2 or the PRKN genes were found to live longer than those…